Media-OutReach Newswire AIM Vaccine’s heavyweight single-product mRNA RSV Vaccine obtained the clinical trial approval
Media-OutReach Newswire Phase III clinical data of AIM Vaccine iterative serum-free rabies vaccine reaches preset goals
Media-OutReach Newswire Merck Launches First All-in-One Genetic Stability Assay to Accelerate Biosafety Testing